Clinical trial

Reandron in Diabetic Men Witn Low Testosterone Level

NCT00613782

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2009-01-01

PhasePHASE2 / PHASE3

Study timeline

Study start (unknown)2009-01-01Date precision: month

Registry last updated2014-07-01

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetesverified · MONDO: type 2 diabetes mellitus

Hypogonadismverified · MONDO: hypogonadism

Interventions

Reandron 1000DRUG

placeboDRUG

Sponsors & collaborators

Austin Healthlead sponsor

Mapped research locations

MelbourneVictoria, Australia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00613782 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.